Insufficient scRNA-seq data for expression of YJU2 at single-cell level.
Insufficient scRNA-seq data for expression of YJU2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1029.69 | 258 / 258 | 100% | 39.72 | 230 / 230 |
esophagus | 100% | 1032.85 | 1445 / 1445 | 100% | 28.57 | 183 / 183 |
liver | 100% | 671.46 | 226 / 226 | 100% | 34.66 | 406 / 406 |
ovary | 100% | 1132.76 | 180 / 180 | 100% | 26.33 | 430 / 430 |
pancreas | 100% | 845.15 | 328 / 328 | 100% | 34.26 | 178 / 178 |
thymus | 100% | 1210.81 | 653 / 653 | 100% | 57.50 | 605 / 605 |
uterus | 100% | 1157.89 | 170 / 170 | 100% | 44.35 | 459 / 459 |
brain | 100% | 984.03 | 2638 / 2642 | 100% | 69.04 | 705 / 705 |
kidney | 100% | 949.73 | 89 / 89 | 100% | 36.32 | 898 / 901 |
skin | 100% | 1210.55 | 1809 / 1809 | 100% | 45.79 | 470 / 472 |
prostate | 100% | 1191.24 | 245 / 245 | 99% | 48.25 | 499 / 502 |
breast | 100% | 1116.97 | 459 / 459 | 99% | 37.05 | 1110 / 1118 |
intestine | 100% | 1036.67 | 966 / 966 | 99% | 40.17 | 523 / 527 |
stomach | 100% | 964.48 | 358 / 359 | 99% | 34.18 | 284 / 286 |
bladder | 100% | 1057.52 | 21 / 21 | 99% | 41.81 | 498 / 504 |
lung | 100% | 856.34 | 577 / 578 | 99% | 31.02 | 1140 / 1155 |
adipose | 100% | 991.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 68.37 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 80.12 | 29 / 29 |
spleen | 100% | 1297.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 59.86 | 1 / 1 |
muscle | 100% | 855.03 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 913.30 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 569.03 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 837.57 | 914 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008380 | Biological process | RNA splicing |
GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0000349 | Biological process | generation of catalytic spliceosome for first transesterification step |
GO_0071006 | Cellular component | U2-type catalytic step 1 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | YJU2 |
Protein name | Splicing factor YJU2 (Coiled-coil domain-containing protein 94) YJU2 splicing factor homolog |
Synonyms | CCDC94 |
Description | FUNCTION: Part of the spliceosome which catalyzes two sequential transesterification reactions, first the excision of the non-coding intron from pre-mRNA and then the ligation of the coding exons to form the mature mRNA . Plays a role in stabilizing the structure of the spliceosome catalytic core and docking of the branch helix into the active site, producing 5'-exon and lariat intron-3'-intermediates (By similarity). May protect cells from TP53-dependent apoptosis upon dsDNA break damage through association with PRP19-CD5L complex . . |
Accessions | ENST00000262962.12 M0R2S3 ENST00000596496.1 Q9BW85 |